Beiersdorf, DE0005200000

Bernstein keeps EUR 95 target for Beiersdorf stock

Published on 10/15/2026 at 10:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Bernstein kept its Buy rating and EUR 95.00 target on October 13, 2026. Beiersdorf stock costs EUR 81.55, plus 0.68 percent versus the Xetra close.

Recovery rests on execution

Bernstein maintained its EUR 95.00 target on October 13, 2026.
Consumer business sales reached EUR 4.113 billion in the first half of 2026 at minus 4.00 percent organic growth.
Beiersdorf stock trades at EUR 81.55 at 10:41 a.m. CEST at Lang & Schwarz on October 15, 2026, 0.68 percent above the Xetra close of October 14, 2026.

Geometrisches Bauhaus-Poster mit Formen und den Begriffen Skincare und Cosmetics — Bauhaus-Poster mit geometrischen Formen und branchentypischem Sektor-Text visualisiert das Unternehmen Beiersdorf AG, ISIN DE0005200000, Illustration mit AI erstellt.

Beiersdorf stock (ISIN DE0005200000) was trading at EUR 81.55 at Lang & Schwarz on October 15, 2026, at 10:41 a.m. CEST, up 0.68 percent versus the Xetra close of October 14, 2026 at EUR 81.00. The latest analyst signal came from Bernstein, which maintained a Buy rating and a EUR 95.00 target on October 13, 2026, according to MarketScreener.

First-half figures set the test

The analyst view meets a mixed operating picture. Beiersdorf's consumer business generated EUR 4.113 billion in net sales during the first half of 2026, with organic sales declining 4.00 percent, while the company said its Derma business grew 7.80 percent in the same period. Those figures came from the H1 results call published by Yahoo Finance.

The contrast explains why the EUR 95.00 target depends on execution rather than a simple recovery in the core brand. Management said NIVEA sales fell 6.80 percent organically in the first half of 2026, while Derma continued to expand through innovation and regional growth. The same call said Beiersdorf planned an additional EUR 100 million of NIVEA investment in the second half of 2026.

Three dated signals shape the story

On August 5, 2026, Beiersdorf reported first-half operating trends including EUR 4.113 billion in consumer net sales and 7.80 percent organic Derma growth, as documented in the Yahoo Finance transcript. On October 12, 2026, the company disclosed purchases of 36,500 shares under its 2026/2027 buyback program, according to Finanznachrichten. On October 13, 2026, Bernstein maintained its EUR 95.00 target, as reported by MarketScreener.

What does the target imply for the stock?

At EUR 81.55, the EUR 95.00 Bernstein target lies 16.86 percent above the Lang & Schwarz price. That spread gives the analyst call a measurable valuation angle, but the operating evidence remains split between Derma growth and NIVEA weakness. Beiersdorf is scheduled to release its third-quarter 2026 sales performance on October 27, 2026, according to the Yahoo Finance transcript.

Execution remains the market question

The next report will show whether the turnaround plan is changing the balance between the brands. For investors, the key comparison is clear: Derma grew 7.80 percent in the first half of 2026, while NIVEA declined 6.80 percent organically over the same period.

Stock trades above the Xetra close

Beiersdorf stock was trading at EUR 81.55 at Lang & Schwarz on October 15, 2026, at 10:41 a.m. CEST, 0.68 percent above the Xetra close of October 14, 2026 at EUR 81.00. The company is listed on Xetra and belongs to the DAX. The further course of trading is shown by the continuously updated real-time quote of Beiersdorf stock.